XML 13 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Share capital
Additional paid-in capital
Contributed surplus
Accumulated other comprehensive income/(loss)
Accumulated profit/(deficit)
Shares outstanding starting balance (in shares) at Dec. 31, 2020   127,810,064        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares issued (in shares)   10,212,876        
Shares outstanding ending balance (in shares) at Jun. 30, 2021   138,022,940        
Equity starting balance at Dec. 31, 2020   $ 1,278 $ 531,382 $ 539,370 $ (19,316) $ (257,063)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares issued, amount   102 85,259      
Payments in lieu of issuing shares     (97)      
Amortization of stock-based compensation     374      
Equity adjustment arising from reacquisition of convertible notes     (492)      
Dividends declared       (35,713)   0
Fair value adjustments to hedging financial instruments         5,497  
Fair value adjustments to available-for-sale securities         (321)  
Other comprehensive (loss)/income $ 51       51  
Net income 51,009         51,009
Equity ending balance at Jun. 30, 2021 $ 901,320 $ 1,380 616,426 503,657 (14,089) (206,054)
Shares outstanding starting balance (in shares) at Dec. 31, 2020   127,810,064        
Shares outstanding ending balance (in shares) at Dec. 31, 2021 138,551,387 138,551,387        
Equity starting balance at Dec. 31, 2020   $ 1,278 531,382 539,370 (19,316) (257,063)
Equity ending balance at Dec. 31, 2021 $ 982,327 $ 1,386 621,037 461,818 (9,194) (92,720)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares issued (in shares)   0        
Shares outstanding ending balance (in shares) at Jun. 30, 2022 138,551,387 138,551,387        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares issued, amount   $ 0 0      
Payments in lieu of issuing shares     0      
Amortization of stock-based compensation     739      
Equity adjustment arising from reacquisition of convertible notes     0      
Dividends declared       (37,256)   (15,994)
Fair value adjustments to hedging financial instruments         13,677  
Fair value adjustments to available-for-sale securities         330  
Other comprehensive (loss)/income $ (120)       (120)  
Net income 104,429         104,429
Equity ending balance at Jun. 30, 2022 $ 1,046,554 $ 1,386 $ 615,913 $ 424,562 $ 4,693 $ 0